M-14766-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Mitomap GenBank:
𝑓 0.76 ( AC: 46208 )
Consequence
CYTB
missense
missense
Scores
Apogee2
Benign
Clinical Significance
No linked disesase in Mitomap
Conservation
PhyloP100: 0.116
Genes affected
CYTB (HGNC:7427): (mitochondrially encoded cytochrome b) Predicted to enable metal ion binding activity. Predicted to be involved in several processes, including electron transport coupled proton transport; response to cobalamin; and response to glucagon. Located in mitochondrion. Implicated in ovarian carcinoma and urinary bladder cancer. [provided by Alliance of Genome Resources, Apr 2022]
ND6 (HGNC:7462): (mitochondrially encoded NADH dehydrogenase 6) Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Predicted to be located in mitochondrial inner membrane. Implicated in Leber hereditary optic neuropathy; Leigh disease; and spinal muscular atrophy with lower extremity predominante 2B. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant M-14766-C-T is Benign according to our data. Variant chrM-14766-C-T is described in ClinVar as [Benign]. Clinvar id is 140587.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
High frequency in mitomap database: 0.7558
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYTB | unassigned_transcript_4818 | c.20C>T | p.Thr7Ile | missense_variant | Exon 1 of 1 | |||
ND6 | unassigned_transcript_4816 | c.-93G>A | upstream_gene_variant | |||||
TRNE | unassigned_transcript_4817 | c.-24G>A | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap GenBank
AF:
AC:
46208
Gnomad homoplasmic
AF:
AC:
39641
AN:
56086
Gnomad heteroplasmic
AF:
AC:
3
AN:
56086
Alfa
AF:
Hom.:
Mitomap
No disease associated.
ClinVar
Significance: Benign
Submissions summary: Pathogenic:2Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Venous thromboembolism Pathogenic:1
-
Genomics Division, Defence Institute of Physiology and Allied Sciences
Significance: Likely risk allele
Review Status: no assertion criteria provided
Collection Method: case-control
- -
Familial cancer of breast Pathogenic:1
-
Department of Zoology Govt. MVM College
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only
- -
Leigh syndrome Benign:1
Oct 17, 2019
Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The NC_012920.1:m.14766C>T (YP_003024038.1:p.Thr7Ile) variant in MTCYB gene is interpretated to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: BA1 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Apogee2
Benign
Hmtvar
Benign
AlphaMissense
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at